Completed
Topics
The workshop examined disability associated with stem cell treatment. It included presentations on the functional outcomes for individuals who have received hematopoietic stem cell treatment, as well as medical advances, developments, and research in this area.
Featured publication
Workshop
·2022
The Board on Health Care Services of the National Academies of Sciences, Engineering and Medicine hosted a virtual workshop, funded by the Social Security Association, to examine disability associated with hematopoietic stem cell transplantation. The workshop, held on November 15, 2021, included pre...
View details
Description
A planning committee of the National Academies of Sciences, Engineering, and Medicine (the National Academies) will plan and host a 1 to 2-day public workshop that will facilitate a discussion focused on disability associated with stem cell treatment. In particular, the workshop shall include presentations on the functional outcomes for individuals who have received stem cell transplantation or other stem cell treatment, as well as medical advances, developments, and research in this area.
The workshop shall feature invited presentations and panel discussions on issues such as:
• A general overview of stem cell treatments and the current and potential purposes for their use;
• Laboratory or other findings in the medical or treating record to identify at what point stem cell transplantation is necessary;
• Processes conducted to identify stem cell treatment or transplantation recipients with the highest probability of positive post-treatment outcomes;
• Current outcome measures for assessing the effectiveness of care for individuals who have received stem cell treatment or transplantation (for example, morbidity and mortality);
• Supplemental treatments used to improve a person’s physical or mental functioning following stem cell treatment or transplantation, and the settings in which the treatments are provided;
• The typical length of time from the initiation of stem cell treatment or transplant surgery until the person’s functioning improves to the point of which the condition is no longer disabling, and specific ages or other recipient traits where improvement is more likely;
• Laboratory or other findings used to assess medical and functional improvement after stem cell treatment or transplantation; and
• Recent medical advances, promising research, or new technologies that may alter expected patient outcomes, and potential advances anticipated in the near future.
The planning committee shall develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceeding of the presentations and discussions at the workshop shall be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
Social Security Administration
Staff
Laura Aiuppa
Lead
Adrienne Formentos
Rukshana Gupta